Data / Form D filings / Pyxant Labs Inc
Pyxant Labs Inc: Form D filings
Pyxant Labs Inc, a biotechnology company in Colorado Springs, CO, filed 4 Form D notices with the SEC between 2014 and 2017. The latest, on July 13, 2017, reports $1.1 million sold of a $1.5 million offering to 17 investors.
Find out what Pyxant Labs Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4720 FORGE RD, SUITE 108, Colorado Springs, CO, 80907
- Phone
- (719) 593-1165
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Colorado
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 1364214
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 13, 2017 | Amendment | $1,500,000 | $1,103,000 | $397,000 | 17 | Feb 1, 2016 | sec.gov |
| Aug 3, 2016 | Amendment | $1,000,000 | $530,000 | $470,000 | 9 | Feb 1, 2016 | sec.gov |
| Mar 1, 2016 | New notice | $650,000 | $440,000 | $210,000 | 6 | Feb 1, 2016 | sec.gov |
| Mar 20, 2014 | New notice | $690,000 | $690,000 | $0 | 10 | Jan 30, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Maurice A. Gaubatz | Executive Officer, Director | |
| John A. Gloriod | Director | |
| Lee A. Daniel III | Director | |
| Jean A. Pineault | Executive Officer | |
| Dean P. Stull | Director | |
| Randall H. Guthrie | Executive Officer |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Jul 10, 2017 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Pyxant Labs Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.